Terms: = Brain cancer AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306 AND Prognosis
5 results:
1. Transcription Factors Leading to High Expression of Neuropeptide L1CAM in brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis.
Feng X; Guan N; Xu E; Miao Y; Li C
Dis Markers; 2021; 2021():8585633. PubMed ID: 35003395
[TBL] [Abstract] [Full Text] [Related]
2. Central nervous system ALK-negative anaplastic large cell lymphoma with irf4/DUSP22 rearrangement.
Magaki S; Satyadev R; Chen Z; Yung KS; Vinters HV; Kinney MC; Said JW
Brain Tumor Pathol; 2022 Jan; 39(1):25-34. PubMed ID: 34791573
[TBL] [Abstract] [Full Text] [Related]
3. Interferon regulatory factor transcript levels correlate with clinical outcomes in human glioma.
Lei J; Zhou MH; Zhang FC; Wu K; Liu SW; Niu HQ
Aging (Albany NY); 2021 Apr; 13(8):12086-12098. PubMed ID: 33902005
[TBL] [Abstract] [Full Text] [Related]
4. Differential correlation analysis of glioblastoma reveals immune ceRNA interactions predictive of patient survival.
Chiu YC; Wang LJ; Lu TP; Hsiao TH; Chuang EY; Chen Y
BMC Bioinformatics; 2017 Feb; 18(1):132. PubMed ID: 28241741
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma.
Kreher S; Jöhrens K; Strehlow F; Martus P; Borowiec K; Radke J; Heppner F; Roth P; Thiel E; Pietsch T; Weller M; Korfel A
Neuro Oncol; 2015 Jul; 17(7):1016-21. PubMed ID: 25817328
[TBL] [Abstract] [Full Text] [Related]
